{
    "Trade/Device Name(s)": [
        "TD-4183 Blood Glucose Monitoring System",
        "TD-4183 Blood Glucose meter",
        "TD-4183 Blood Glucose Test Strips"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K190579",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "June 4, 2019",
    "Summary Letter Received Date": "March 6, 2019",
    "Submission Date": "May 10, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood from the fingertip"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TD-4183 Blood Glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology",
        "Amperometric glucose biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for TaiDoc TD-4183 Blood Glucose Monitoring System for home glucose measurement using amperometric biosensor technology",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from the fingertip for self-testing at home by people with diabetes mellitus as an aid in monitoring diabetes control; single-person use only; not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}